SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-031966
Filing Date
2018-05-10
Accepted
2018-05-10 08:01:13
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8647_110q.htm 10-Q 845315
2 EX-31.1 a18-8647_1ex31d1.htm EX-31.1 12643
3 EX-31.2 a18-8647_1ex31d2.htm EX-31.2 12731
4 EX-32.1 a18-8647_1ex32d1.htm EX-32.1 7130
  Complete submission text file 0001104659-18-031966.txt   3411051

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20180331.xml EX-101.INS 627235
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20180331.xsd EX-101.SCH 29491
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20180331_cal.xml EX-101.CAL 36436
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20180331_lab.xml EX-101.LAB 290403
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20180331_pre.xml EX-101.PRE 201045
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20180331_def.xml EX-101.DEF 87741
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 18820569
SIC: 2834 Pharmaceutical Preparations